Similar articles

• [Treatment alternatives in mechanical valve thrombosis].

  Duran NE, Biteker M, Ozkan M. Duran NE, et al. Turk Kardiyol Dern Ars. 2008 Sep;36(6):420-5. Turk Kardiyol Dern Ars. 2008. PMID: 19155650 Review. Turkish.
• Long-term anticoagulation with fondaparinux in a patient with a mechanical heart valve.

  Nagler M, Haslauer M, Wuillemin WA. Nagler M, et al. Ann Hematol. 2011 Oct;90(10):1225-6. doi: 10.1007/s00277-010-1143-6. Epub 2011 Jan 5. Ann Hematol. 2011. PMID: 21207030 No abstract available.
• Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.

  Stefanidis A, Skafidas D, Papasteriadis E. Stefanidis A, et al. Eur Heart J. 2007 Oct;28(20):2552-3; author reply 2553-4. doi: 10.1093/eurheartj/ehm353. Epub 2007 Sep 6. Eur Heart J. 2007. PMID: 17823214 No abstract available.
• Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.

  Colli A, Verhoye JP, Leguerrier A, Gherli T. Colli A, et al. Eur J Cardiothorac Surg. 2007 Apr;31(4):573-7. doi: 10.1016/j.ejcts.2007.02.002. Epub 2007 Feb 21. Eur J Cardiothorac Surg. 2007. PMID: 17317197 Review.
• Incidence of anticoagulation in patients with bioprostheses.

  Gherli T, Colli A, Nicolini F. Gherli T, et al. J Heart Valve Dis. 2004 May;13 Suppl 1:S88-9. J Heart Valve Dis. 2004. PMID: 15225014 No abstract available.